| P2093 | author name string | Martin Gasser | |
| | Christoph-Thomas Germer | |
| | Uwe Maeder | |
| | Volker Kunzmann | |
| | Alexander D Miras | |
| | Florian Seyfried | |
| | Jörg Pelz | |
| | Alexander G Kerscher | |
| | Burkhard H von Rahden | |
| P2860 | cites work | Japanese gastric cancer treatment guidelines 2010 (ver. 3). | Q51568719 |
| | Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. | Q51930690 |
| | Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer | Q53452457 |
| | Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. | Q53496077 |
| | [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. | Q55054165 |
| | Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis | Q60629647 |
| | Recurrence following curative resection for gastric carcinoma | Q73442414 |
| | Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study | Q73447733 |
| | Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer | Q73552404 |
| | Prospective study of peritoneal recurrence after curative surgery for gastric cancer | Q73876936 |
| | Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer | Q75244449 |
| | The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification | Q83498873 |
| | Factors affecting recurrence in node-negative advanced gastric cancer | Q83901605 |
| | Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy | Q84302683 |
| | Global cancer statistics | Q22241238 |
| | Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 |
| | Cancer statistics, 2013 | Q27860762 |
| | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 |
| | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 |
| | Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials | Q31150068 |
| | Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma | Q33657791 |
| | Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure | Q33855586 |
| | Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research | Q34581504 |
| | Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). | Q34583807 |
| | Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q34620678 |
| | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | Q34634936 |
| | Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q34656353 |
| | Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis | Q35761049 |
| | Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes | Q35768031 |
| | Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity | Q36097149 |
| | Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). | Q36746989 |
| | Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis | Q37676972 |
| | Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis | Q37742318 |
| | Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity | Q37895575 |
| | A proposal of a practical and optimal prophylactic strategy for peritoneal recurrence | Q38000556 |
| | Colorectal cancer screening--optimizing current strategies and new directions | Q38079126 |
| | Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma | Q40552455 |
| | Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma | Q43853697 |
| | Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors | Q43880060 |
| | Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection | Q44596612 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 73 | |
| P577 | publication date | 2015-02-19 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients | |
| P478 | volume | 15 | |